Barbara Hoefgen

Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families

Sibylle G. Schwab, Barbara Hoefgen, Claudia Hanses et al. · Biological Psychiatry · 2005 · 157 citations

Life Sciences, Genetics, Molecular Genetics +14

The power of sample size and homogenous sampling: Association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder

Barbara Hoefgen, Thomas G. Schulze, Stephanie Ohlraun et al. · Biological Psychiatry · 2005 · 156 citations

Medicine, Biostatistics, Psychiatry +17

Dopamine/Serotonin Receptor Ligands. 10: SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D₁, D_2L, and D₅ Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D₁/D₅ Selective Antagonist

Barbara Hoefgen, Michael Decker, Patrick Mohr et al. · Journal of Medicinal Chemistry · 2005 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Association of DNA Polymorphisms in the Synaptic Vesicular Amine Transporter Gene (SLC18A2) with Alcohol and Nicotine Dependence

Sibylle G. Schwab, Petra Franke, Barbara Hoefgen et al. · Neuropsychopharmacology · 2005 · 42 citations · Full text

Life Sciences, Genetics, Neuroscience +16

Dopamine/Serotonin Receptor Ligands, Part III [1]: Synthesis and Biological Activities of 7, 7′—Alkylene-bis-6, 7, 8, 9, 14, 15-hexahydro-5H-benz[d]indolo[2, 3-g]azecines — Application of the Bivalent Ligand Approach to a Novel Type of Dopamine Receptor Antagonist

Stefan Lankow, Barbara Hoefgen, Michael Decker et al. · Archiv der Pharmazie · 2002 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +17